SCHEMBL8305982

SCHEMBL8305982

CCOC(=O)C(F)(F)C(O)c1ccncc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NAMPT P43490 1/20 0.40
MAPK1 P28482 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
ABCB11 O95342 1/20 0.37
CYP1A2 P05177 1/20 0.37
CYP3A4 P08684 1/20 0.37
TSHR P16473 1/20 0.37
HTR2A P28223 1/20 0.37
PMP22 Q01453 1/20 0.37
PPARA Q07869 1/20 0.37
CDC7 O00311 3/20 0.37
DBF4 Q9UBU7 3/20 0.37
NPSR1 Q6W5P4 2/20 0.37
POLB P06746 1/20 0.37
PPID Q08752 1/20 0.36
LATS1 O95835 1/20 0.36
CYP19A1 P11511 1/20 0.36
ADRB2 P07550 1/20 0.36
ADRB1 P08588 1/20 0.36
ADRB3 P13945 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1143435 0.84 POLB (0.48) TSHRNPSR1POLBMAPTPIN1
SCHEMBL29570205 0.83 MAPT (0.46) MAPK1SMN1; SMN2ABCB11CYP1A2CYP3A4
SCHEMBL27167866 0.82 NPSR1 (0.44) MAPK1SMN1; SMN2ABCB11CYP1A2CYP3A4
SCHEMBL25220032 0.82 ABCB11 (0.54) SMN1; SMN2ABCB11CYP1A2CYP3A4TSHR
SCHEMBL3627581 0.82 LMNA (0.46) SMN1; SMN2ABCB11CYP1A2CYP3A4TSHR
SCHEMBL6487474 0.81 GABBR2 (0.52) ABCB11CYP1A2CYP3A4TSHRHTR2A
SCHEMBL10021191 0.79 TAAR1 (0.41) PPARAKMT2A
SCHEMBL8937686 0.78 ALDH1A1 (0.38) NAMPTCDC7DBF4PPIDCYP19A1
SCHEMBL3623374 0.77 ALDH1A1 (0.51) SMN1; SMN2POLBKDM4EMAPTGAA
SCHEMBL7805080 0.75 SMN1; SMN2 (0.52) MAPK1SMN1; SMN2ABCB11CYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0583421-B1 SUBSTITUTED DIBENZOXAZEPINE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE SEARLE & CO (US) 1999-06-16 EP disclosed
EP-0512400-B1 Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use SEARLE & CO (US) 1998-12-02 EP disclosed
US-5576315-A Substituted dibenzoxazepine compounds and methods for treating osteoporosis and ischemia G.D. SEARLE & CO. (US) 1996-11-19 US disclosed
US-5464830-A ANALGESICS G. D. SEARLE & CO. (US) 1995-11-07 US disclosed
US-5378840-A Substituted dibenzoxazepine compounds G. D. SEARLE & CO. (US) 1995-01-03 US disclosed
EP-0583421-A1 SUBSTITUTED DIBENZOXAZEPINE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE G.D. SEARLE & CO. (US) 1994-02-23 EP disclosed
WO-1992019617-A2 SUBSTITUTED DIBENZOXAZEPINE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE G.D. SEARLE & CO. (US) 1992-11-12 WO disclosed
EP-0512400-A1 Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use G.D. Searle & Co. (US) 1992-11-11 EP disclosed